Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
December 1, 1983
Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones
R B Gammill, C E Day, P E Schurr
Atherosclerosis
|
September 1, 1985
Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male cynomolgus monkeys fed an atherogenic diet for 18 months
T J Stevens, T J Vidmar, C E Day
Laboratory Animal Science
|
October 1, 1977
Utility of selected line (SEA) of the Japanese quail (Coturnix coturnix japonica) for the discovery of new anti-atherosclerosis drugs
C E Day, W W Stafford, P E Schurr
Atherosclerosis
|
June 1, 1981
The mechanism of action of the hypocholesterolemic drug p-(1-adamantyloxy)-aniline
B D Rush, M J Ruwart, C E Day
Advances in Experimental Medicine and Biology
|
January 1, 1976
High volume screening procedures for hypobetalipoproteinemic activity in rats
P E Schurr, J R Schultz, C E Day
Advances in Experimental Medicine and Biology
|
January 1, 1976
Biological activity of a hypobetalipoproteinemic agent
C E Day, P E Schurr, W E Heyd, et al.
Artery
|
January 1, 1983
Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat
T J Stevens, W W Stafford, C E Day, et al.
Atherosclerosis
|
September 1, 1985
Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male SEA Japanese quail and rats
T J Stevens, P E Schurr, R B Gammill, et al.
Journal of Medicinal Chemistry
|
November 1, 1975
Hypo-beta-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives
C E Day, P E Schurr, D E Emmert, et al.
Journal of Medicinal Chemistry
|
September 1, 1982
Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline
W E Heyd, L T Bell, J R Heystek, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
December 1, 1983
Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones
R B Gammill, C E Day, P E Schurr
Atherosclerosis
|
September 1, 1985
Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male cynomolgus monkeys fed an atherogenic diet for 18 months
T J Stevens, T J Vidmar, C E Day
Laboratory Animal Science
|
October 1, 1977
Utility of selected line (SEA) of the Japanese quail (Coturnix coturnix japonica) for the discovery of new anti-atherosclerosis drugs
C E Day, W W Stafford, P E Schurr
Atherosclerosis
|
June 1, 1981
The mechanism of action of the hypocholesterolemic drug p-(1-adamantyloxy)-aniline
B D Rush, M J Ruwart, C E Day
Advances in Experimental Medicine and Biology
|
January 1, 1976
High volume screening procedures for hypobetalipoproteinemic activity in rats
P E Schurr, J R Schultz, C E Day
Advances in Experimental Medicine and Biology
|
January 1, 1976
Biological activity of a hypobetalipoproteinemic agent
C E Day, P E Schurr, W E Heyd, et al.
Artery
|
January 1, 1983
Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat
T J Stevens, W W Stafford, C E Day, et al.
Atherosclerosis
|
September 1, 1985
Evaluation of timefurone, a new anti-atherosclerotic drug, for its effects on lipoprotein cholesterol in male SEA Japanese quail and rats
T J Stevens, P E Schurr, R B Gammill, et al.
Journal of Medicinal Chemistry
|
November 1, 1975
Hypo-beta-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives
C E Day, P E Schurr, D E Emmert, et al.
Journal of Medicinal Chemistry
|
September 1, 1982
Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline
W E Heyd, L T Bell, J R Heystek, et al.
Page
of 6